We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+53.18%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$4.46B
AUM Growth
+$1.51B
Cap. Flow
+$324M
Cap. Flow %
7.28%
Top 10 Hldgs %
35.21%
Holding
208
New
28
Increased
93
Reduced
71
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 38.6%
2 Healthcare 16.36%
3 Industrials 13.09%
4 Consumer Discretionary 9.99%
5 Communication Services 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAH icon
151
Sonic Automotive
SAH
$2.57B
$3.52M 0.08%
91,376
-624,440
-87% -$25.4M
NGNE icon
152
Neurogene
NGNE
$703M
$3.47M 0.08%
12,315
-2,511
-17% -$614K
KIN
153
DELISTED
Kindred Biosciences, Inc.
KIN
$3.25M 0.07%
752,822
-146,186
-16% -$595K
CTG
154
DELISTED
Computer Task Group, Inc.
CTG
$3.21M 0.07%
524,373
-53,819
-9% -$324K
SILK
155
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$3.01M 0.07%
+47,815
New +$2.97M
FENC icon
156
Fennec Pharmaceuticals
FENC
$440M
$2.94M 0.07%
394,810
-36,660
-8% -$279K
PRLB icon
157
Protolabs
PRLB
$2.17B
$2.92M 0.07%
19,065
-965
-5% -$136K
IRTC icon
158
iRhythm Holdings
IRTC
$4.02B
$2.91M 0.07%
+12,274
New +$2.8M
MPWR icon
159
Monolithic Power Systems
MPWR
$68.6B
$2.89M 0.06%
+7,895
New +$2.53M
KNSL icon
160
Kinsale Capital Group
KNSL
$8.59B
$2.84M 0.06%
14,171
+3,068
+28% +$673K
AXTI icon
161
AXT Inc
AXTI
$4.78B
$2.83M 0.06%
296,000
+62,852
+27% +$505K
TER icon
162
Teradyne
TER
$58.8B
$2.83M 0.06%
23,563
-3,243
-12% -$331K
JNCE
163
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.8M 0.06%
400,013
-71,609
-15% -$557K
ONTO icon
164
Onto Innovation
ONTO
$15.3B
$2.77M 0.06%
58,153
-205,828
-78% -$8.25M
SLAB icon
165
Silicon Laboratories
SLAB
$7.2B
$2.62M 0.06%
20,547
+575
+3% +$64.8K
BLUE
166
DELISTED
bluebird bio
BLUE
$2.6M 0.06%
4,639
-2,681
-37% -$1.7M
BMRA icon
167
Biomerica
BMRA
$4.85M
$2.54M 0.06%
63,865
+52,649
+469% +$2.64M
PFPT
168
DELISTED
Proofpoint, Inc.
PFPT
$2.46M 0.06%
18,039
+299
+2% +$32.8K
EXPE icon
169
Expedia Group
EXPE
$38.8B
$2.41M 0.05%
+18,204
New +$2.05M
NEWR
170
DELISTED
New Relic, Inc.
NEWR
$2.38M 0.05%
36,473
-551
-1% -$34K
XENE icon
171
Xenon Pharmaceuticals
XENE
$6.19B
$2.36M 0.05%
153,321
-5,383
-3% -$63K
PCTY icon
172
Paylocity
PCTY
$7.74B
$2.17M 0.05%
10,544
-161,077
-94% -$31M
RNG icon
173
RingCentral
RNG
$5.31B
$2.12M 0.05%
+5,589
New +$1.74M
EXAS
174
DELISTED
Exact Sciences
EXAS
$2.1M 0.05%
15,876
-29,393
-65% -$3.55M
CHEF icon
175
Chefs' Warehouse
CHEF
$4.47B
$1.94M 0.04%
+75,431
New +$1.48M

Similar funds

Granahan Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Granahan Investment Management held 208 positions worth $4.46B, up 51% from $2.95B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Granahan Investment Management deployed $324M of net new capital in Q4 2020, opening 28 new positions and adding to 93 existing holdings. Its largest new stake was dMY Technology Group, Inc. II: 3,436,892 shares worth $60.5M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Magnite, an estimated $50.1M trimmed.

  • Granahan Investment Management's largest Q4 2020 buy was dMY Technology Group, Inc. II: 3,436,892 shares worth $60.5M.
  • Granahan Investment Management added most to Workiva in Q4 2020, an estimated $52.1M increase.
  • Granahan Investment Management's biggest Q4 2020 reduction was Magnite, cutting an estimated $50.1M.
  • Granahan Investment Management fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $33.7M.
  • Granahan Investment Management's ten largest holdings make up 35% of its $4.46B portfolio in Q4 2020.
  • Granahan Investment Management opened 28 new positions and closed 16 in Q4 2020.
  • Granahan Investment Management's portfolio value rose 51% quarter-over-quarter to $4.46B.

Based on Granahan Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.